duration of prednisolone thrapy in ITP
Not Applicable
- Conditions
- ITP.immune thrombocytopenic purpura
- Registration Number
- IRCT201109147553N1
- Lead Sponsor
- Arak university of medical sciences and health services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
ITP with thrombocytopenia and normal CBC and normal peripheral blood smear.
exclusion criteria: secondary ITP due to some diseases such as: lupus, antiphospholipid syndrom,CLL and infections.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet count. Timepoint: monthly till 6 months after treatment course. Method of measurement: CBC-Diff. and Plt. count/micro liter.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: before and after treatment course. Method of measurement: via sphygmomanometer. mm.Hg.